APA (7th ed.) Citation

Fuh, F., Tew, W., Keir, M., Looney, C., Maciuca, R., McBride, J., & Ramirez-Montagut, T. (2017). Su1938 - Colonic Treg Levels are Reduced in Patients with UC Achieving Clinical Remission, but are not Differentially Affected by Etrolizumab Dose. Gastroenterology (New York, N.Y. 1943), 152(5), S603-S604. https://doi.org/10.1016/S0016-5085(17)32154-6

Chicago Style (17th ed.) Citation

Fuh, Franklin, Wei Tew, Mary Keir, Caroline Looney, Romeo Maciuca, Jacqueline McBride, and Teresa Ramirez-Montagut. "Su1938 - Colonic Treg Levels Are Reduced in Patients with UC Achieving Clinical Remission, but Are Not Differentially Affected by Etrolizumab Dose." Gastroenterology (New York, N.Y. 1943) 152, no. 5 (2017): S603-S604. https://doi.org/10.1016/S0016-5085(17)32154-6.

MLA (9th ed.) Citation

Fuh, Franklin, et al. "Su1938 - Colonic Treg Levels Are Reduced in Patients with UC Achieving Clinical Remission, but Are Not Differentially Affected by Etrolizumab Dose." Gastroenterology (New York, N.Y. 1943), vol. 152, no. 5, 2017, pp. S603-S604, https://doi.org/10.1016/S0016-5085(17)32154-6.